Clicky

Integragen(ALINT)

Description: IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.


Keywords: Biotechnology Cancer Life Sciences Biology Molecular Biology Genomics DNA Clinical Research Services DNA Sequencing Genotyping SNP Personal Genomics Pharmacogenomics Genomic Services Human Genome Epigenomics Transcriptomics

Home Page: integragen.com

Genopole Campus 1 BAt. 8
Évry, 91000
France
Phone: 33 1 60 91 09 00


Officers

Name Title
Dr. Bernard Courtieu DVM, MBA CEO & Director
Ms. Anne Philippi Co-Founder and Director of Bio-Statistics & Genetic Epidemiology
Mr. Pierre Flamant Admin. & Financial Director
Mr. Emmanuel Martin Chief Operations Officer
Mr. Joerg Leenings Head of Sales & Marketing - Competence Centre
Ms. Bérengère Génin Head of Academics, Research & Hospitals Bus. unit
Mr. Jean-Pol Detiffe Chief Strategy & Innovation Officer and Director

Exchange: PA

Country: FR

Currency: Euro (€)

Forward PE: 0
Trailing PE: 33.25
Price-to-Book MRQ: 3.9088
Price-to-Sales TTM: 0.6337
IPO Date:
Fiscal Year End: December
Full Time Employees: 52
Back to stocks